Pioglitazone for Oral Premalignant Lesions
Condition(s):Oral LeukoplakiaLast Updated:April 6, 2016Terminated
Hide Studies Not Open or Pending
Condition(s):Oral LeukoplakiaLast Updated:April 6, 2016Terminated
Condition(s):Lip and Oral Cavity Cancer; Oral Leukoplakia; Oropharyngeal Cancer; Tongue CancerLast Updated:December 19, 2014Completed
Condition(s):Head and Neck CancerLast Updated:April 12, 2013Completed
Condition(s):Leukoplakia; LichenLast Updated:May 17, 2017Completed
Condition(s):Vulvar Lichen SclerosusLast Updated:February 5, 2024Recruiting
Condition(s):Head and Neck Cancer; Precancerous ConditionLast Updated:July 11, 2013Completed
Condition(s):Oral Leukoplakia; Oral CancerLast Updated:December 15, 2009Unknown status
Condition(s):Precancerous ConditionLast Updated:August 12, 2013Completed
Condition(s):Leukoplakia; ErythroplakiaLast Updated:March 24, 2015Completed
Condition(s):Leukoplakia, Oral; Benign NeoplasmsLast Updated:November 19, 2020Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.